Corrigendum to: "The Rho kinase (ROCK) inhibitor Y-27632 reduces the β 2-adrenoceptor density but enhance cAMP formation in primary equine bronchial epithelial cells" [Eur. J. Pharmacol. 2021 Sep 15; 907:174323]
Eur J Pharmacol. 2022 Jan 15:915:174724.
doi: 10.1016/j.ejphar.2021.174724.
Epub 2021 Dec 22.
1 University of Leipzig, Faculty of Veterinary Medicine, Institute of Pharmacology, Pharmacy and Toxicology, An den Tierkliniken 15, 04103, Leipzig, Germany.
2 Rudolf-Boehm-Institute of Pharmacology and Toxicology, Clinical Pharmacology, Faculty of Medicine, University of Leipzig, Härtelstr. 16 -18, D-04107, Leipzig, Germany. Electronic address: Ralf.Regenthal@medizin.uni-leipzig.de.
3 University of Leipzig, Faculty of Veterinary Medicine, Institute of Pharmacology, Pharmacy and Toxicology, An den Tierkliniken 15, 04103, Leipzig, Germany. Electronic address: gabraham@rz.uni-leipzig.de.